| HOME >> MEDICINE >> TECHNOLOGY |
Media Contact:Doug Sherk/Gregory Gin
Janine McCargoEVC Group
EVC Group415-568-4887/646-445-4801
646-688-0425 DELCATH SYSTEMS, INC.(A Development Stage Company)Condensed Consolidated Statements of Operations and Comprehensive Lossfor the Three Months Ended March 31, 2012 and 2011 andCumulative from Inception (August 5, 1988) to March 31, 2012(in thousands, except share and per share data)Cumulative from
inception
(August 5, 1988) to
March 31, 201Three months ended March 31,20122011Costs and expensesGeneral and administrative expenses(1)$
7,423$
4,166$
68,571Research and development costs(1)7,1313,64888,894Total costs and expenses14,5547,814157,465Operating loss(14,554)(7,814)(157,465)Derivative instrument income (expense)(338)5,966(5,471)Interest income3-2,880Other expense and interest expense--(274)Net loss$
(14,889)$
(1,848)$
(160,330)Common share data:Basic and diluted loss per share$
(0.31)$
(0.04)Weighted average number of basic and diluted common shares outstanding48,341,67042,953,553Comprehensive Loss$
(14,889)$
(1,856)$
(160,376)Note 1:Includes non-cash stock-based compensation as follows:Three months ended March 31, 20122011General and administrative expenses$
563$
887Research and development costs370406Total stock-based compensation expense
$
933$
1,293 DELCATH SYSTEMS, INC.(A Development Stage Company)Condensed Consolidated Balance Sheets as of March 31, 2012 and December 31, 2011(in thousands, except share data) March 31, December 31, 20122011Assets:Current assetsCash and cash equivalents$
17,050$
25,777Inves
'/>"/>
| SOURCE Delcath Systems, Inc. Copyright©2010 PR Newswire. All rights reserved |